Pugh, Trevor J TJ; Bell, Jonathan L JL; Bruce, Jeff P JP; Doherty, Gary J GJ; Galvin, Matthew M; Green, Michelle F MF; Hunter-Zinck, Haley H; Kumari, Priti P; Lenoue-Newton, Michele L ML; Li, Marilyn M MM; Lindsay, James J; Mazor, Tali T; Ovalle, Andrea A; Sammut, Stephen-John SJ; Schultz, Nikolaus N; Yu, Thomas V TV; Sweeney, Shawn M SM; Bernard, Brady B; ,
Impaired SHP2-mediated extracellular signal-regulated kinase activation contributes to gefitinib sensitivity of lung cancer cells with epidermal growth factor receptor-activating mutations.
Cancer Research
Lazzara, Matthew J MJ; Lane, Keara K; Chan, Richard R; Jasper, Paul J PJ; Yaffe, Michael B MB; Sorger, Peter K PK; Jacks, Tyler T; Neel, Benjamin G BG; Lauffenburger, Douglas A DA
Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients.
British Journal Of Cancer
Koivunen, J P JP; Kim, J J; Lee, J J; Rogers, A M AM; Park, J O JO; Zhao, X X; Naoki, K K; Okamoto, I I; Nakagawa, K K; Yeap, B Y BY; Meyerson, M M; Wong, K-K KK; Richards, W G WG; Sugarbaker, D J DJ; Johnson, B E BE; Jänne, P A PA